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Abstract
Background: The repair of alveolar bone defects with growth factors and bone grafting materials has played a
pivotal role in modern dentistry. Recombinant human bone morphogenetic protein-2 (rhBMP2), an osteoinductive
growth factor capable of cell recruitment and differentiation towards the osteoblast lineage, has been utilized in
combination with various biomaterials to further enhance new bone formation. Recently, a group of novel biphasic
calcium phosphate (BCP) bone grafting materials have been demonstrated to possess osteoinductive properties by
demonstrating signs of ectopic bone formation. The aim of the present study was to study the effects of rhBMP2 in
combination with osteoinductive BCP bone grafts on osteoblast cell behaviour.
Methods: MC3T3-E1 pre-osteoblasts were seeded on 1) control tissue culture plastic, 2) 10 mg of BCP alone, 3) 100 ng
rhBMP2, and 4) 100 ng rhBMP2+ 10 mg of BCP and analyzed for cell recruitment via a Transwell chamber, proliferation
via an MTS assay and differentiation as assessed by alkaline phosphatase (ALP) activity, alizarin red staining
and real-time PCR for osteoblast differentiation markers including Runx2, collagen1, ALP, and osteocalcin (OCN).
Results: rhBMP2 was able to significantly upregulate cell recruitment whereas the addition of BCP as well as BCP alone
had no additional ability to improve osteoblast recruitment. Both BCP and rhBMP2 were able to significantly increase
cell proliferation at 3 and 5 days post seeding and cell number was further enhanced when rhBMP2 was combined
with BCP. In addition, the combination of rhBMP2 with BCP significantly improved ALP activity at 7 and 14 days post
seeding, alizarin red staining at 14 days, and mRNA levels of Runx2, ALP and osteocalcin when compared to cells
seeded with rhBMP2 alone or BCP alone.
Conclusions: The results from the present study demonstrate that 1) the osteoinductive potential of BCP bone
particles is equally as osteopromotive as rhBMP2 on in vitro osteoblast differentiation and 2) BCP particles in
combination with rhBMP2 is able to further increase the osteopromotive differentiation of osteoblasts in vitro
when compared to either rhBMP2 alone or BCP alone. Future animal testing is further required to investigate
this combination approach on new bone formation.
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Background
The repair of alveolar bone defects with growth factors
and bone grafting materials have played a pivotal role in
modern dentistry [1–4]. Although autogenous bone has
been considered the gold standard of bone grafting
materials for a number of years due to its excellent com-
bination of osteogenesis (contains living progenitor),
osteoinduction (contains a number of growth factors
capable of recruiting progenitor cells and/or form
ectopic bone formation) and osteoconduction (able to
support three-dimensional tissue ingrowth and future
new bone formation) [5–8]. Despite these advantages,
drawbacks including additional donor site morbidity,
limited harvesting supply within the oral cavity and add-
itional surgical time and costs have necessitated alterna-
tives. These include allografts harvested from human
donors, xenografts harvested from an animal donor and
a wide variety of synthetically fabricated bone grafts
made from hydroxyapatite, tri-calcium phosphate, bi-
phasic calcium phosphate and bioactive glasses [9–13].
Currently, one area of research that has been highly
investigated in recent years is the field of osteoinductive
biomaterials [7]. Originally, osteoinduction was de-
scribed as the ability for an undifferentiated progenitor
cell to auto-induce down the osteoblast lineage [14].
Much of the original findings were developed by Urist
and Strates who extracted a complex of bone morpho-
genetic proteins (BMPs) from demineralized bone matrix
[15]. Since the mid 1970s, the only FDA approved com-
mercially available biomaterials with ‘osteoinductive
potential’ are limited to demineralized freeze-dried bone
allograft (DFDBA) and BMP2 [7]. More recently how-
ever, it has been shown that synthetically fabricated bone
grafts made from biphasic calcium phosphate (BCP)
materials sintered at low temperatures have shown the
potential for osteoinduction by demonstrating ectopic
bone formation when materials were implanted in extra-
skeletal sites (either muscle or epithelial tissues) [16, 17].
As the ability for these materials to guide mesenchymal
progenitor cells down the osteoblast lineage without the
use of inductive growth factors such as BMP2, our la-
boratory has become increasingly interested in their po-
tential as future regenerative materials. One of the main
thoughts contributing to their osteoinductive potential
has been proposed to be highly regulated from cells
derived from the monocyte lineage including either
macrophages or osteoclasts [18]. Currently, an array
of recent research has been carried out investigating
these materials and their ability to induce ectopic
bone formation [19–23].
A recently published article from our group investi-
gated the in vitro characterization of these novel
osteoinductive scaffolds. It was shown that an equal abil-
ity to promote rapid transformation of mesenchymal
progenitor cells towards the osteoblast lineage was
found between BCP bone grafts and autogenous bone by
improving mRNA levels of runx2, collagen 1, alkaline
phosphatase and osteocalcin [24]. These novel BCP bone
grafts differ from previous versions of BCP as they con-
tain more micro- and nano-topographies which are
spontaneously able to induce ectopic bone formation
and are thought to contribute more rapidly to new bone
formation. Thus, it becomes a hypothesis that the com-
bination of BCP and rhBMP2 may potentially be com-
bined to improve new bone formation. The mode of
action of BMP2 is to recruit progenitor cells to defect
sites and guide their differentiation towards the osteo-
blast lineage [25]. In contrast, although these novel BCP
scaffolds have previously reported no ability to recruit
cells, they auto-induce a form of osteoinduction by com-
pletely different mechanisms guiding mesenchymal stem
cell (MSC) differentiation towards the osteoblast lineage
likely due material surface cues guided by topography
and possibly dissolution of the material. Due to the dif-
ferent mechanisms by which BMP2 and BCP scaffolds
are able to induce osteoinduction, it thus becomes of
interest to combine both materials to determine if the
bone inducing capabilities of BMP2 can be enhanced via
its combination with osteoinductive BCP scaffolds.
Therefore, the aim of the present study was to combine
BMP2 with BCP bone grafts and test their ability on in
vitro cell behaviour when compared to BMP2 alone,
BCP alone as well as to tissue culture plastic alone. Cells
were compared for cell recruitment, cell proliferation
and cell differentiation as assessed by alkaline phosphat-
ase activity, alizarin red staining for mineralization as
well as real-time PCR for osteoblast differentiation
markers including Runx2, collagen 1, alkaline phosphat-
ase and osteocalcin.
Methods
BMP2 gene sequence and biphasic calcium phosphate
bone graft
BMP2 was kindly provided by Jiuyuan biotech company
(Hangzhou, China). The amino acid sequence was fabri-
cated as follows: Met Lys Lys Leu Lys Ser Ser Cys Lys
Arg His Pro Leu Tyr Val Asp Phe Ser Asp Val Gly Trp
Asn Asp Trp Ile Val Ala Pro Pro Gly Tyr His Ala Phe
Tyr Cys His Gly Glu Cys Pro Phe Pro Leu Ala Asp His
Leu Asn Ser Thr Asn His Ala Ile Val Gln Thr Leu Val
Asn Ser Val Asn Ser Lys Ile Pro Lys Ala Cys Cys Val Pro
Thr Glu Leu Ser Ala Ile Ser Met Leu Tyr Leu Asp Glu
Asn Glu Lys Val Val Leu Lys Asn Tyr Gln Asp Met Val
Val Glu Gly Cys Gly Cys Arg for a protein chain of 108
amino acids fabricated from E. coli. The concentration
of rhBMP2 used in this study (100 ng/ml) was selected
based on previous concentration dependent experiments
utilizing rhBMP2 (unpublished data). The BCP grafting
Shuang et al. BMC Oral Health  (2017) 17:35 Page 2 of 10
particles were kindly provided by Straumann AG
(Vivoss, Basel, Switzerland) and are composed of hy-
droxyapatite and beta-tricalcium phosphate in a 10:90
ratio with a micro-porous surface structure and a crys-
tallinity ≥80 %. A scanning electron microscopy (SEM)
image of the bone graft can be found in Fig. 1 demon-
strating its macro and micro-rough surface. Previous
studies have described these bone grafts as inducers of
ectopic bone formation [18–23, 26, 27].
Two-dimensional migration assay
MC3T3-E1 pre-osteoblast cell line (ThermoScientific,
Waltham, Massachusetts, United States) was used for
this study. All cells were cultured in tissue culture flasks
using α-MEM supplemented with antibiotics (100 μg/ml
penicillin G, Sigma-Aldrich; 50 μg/ml gentamicin,
Sigma-Aldrich; 3 mg/ml amphotericin B, Gibco, Grand
Island, NY, USA and 10 % fetal bovine serum). No add-
itional osteoblast differentiation media was added for
experiments to fully investigate the potential for each
group to influence MC3T3-E1 pre-osteoblast differenti-
ation towards mineralize-producing osteoblasts. Cells
were removed from the tissue culture plastic using a
trypsin solution [0.25 % trypsin (Gibco), 0.1 % glucose,
citrate-saline buffer (pH 7.8)]. The migration assay of
cells was performed with a Transwell chamber using a
24-well plate and polycarbonate filters (Transwell Costar,
Corning, Acton, MA) with a pore size of 8 μm as previ-
ously described [28]. Ten thousand MC3T3-E1 cells in
50 μl DMEM were seeded in the upper compartment.
Samples included 1) control tissue culture plastic, 2)
10 mg of BCP alone, 3) rhBMP2 at concentrations of
100 ng/ml and 4) rhBMP2 at a concentration of 100 ng/
ml + 10 mg BCP were seeded into the lower compart-
ment. The cells were allowed to migrate for 24 h at 37 °
C in a humidified 5 % CO2 atmosphere. The filter was
then removed, cells were fixed in 4 % formaldehyde for
20 min and washed in PBS, permeabilized in 0.5 %
Triton-X for 15 min, and washed again in phosphate
buffered solution (PBS). After washings, filters were in-
cubated for 1 h at room temperature with Alexa FluorTM
568 phalloidin (1:50 dilution; Invitrogen A12380) diluted
in 0.1 % PBS/BSA. Samples were examined by confocal
microscopy. Non-migrated cells on the upper side were
eliminated by rinsing the filter with cold PBS and scrap-
ing with a rubber wiper. The remaining migrated cells
on the lower side of the filter were counted in nine ran-
dom fields per filter (×100 magnification). All samples
were performed in triplicate with three independent ex-
periments performed and normalized to control samples.
Cell growth assay
To investigate the effect on cell number of MC3T3-E1,
CCK-8 assay for 1) control tissue culture plastic, 2)
10 mg of BCP alone, 3) rhBMP2 at concentrations of
100 ng/ml and 4) rhBMP2 at a concentration of 100 ng/
ml + 10 mg BCP was performed as previously described
[29]. Briefly, cells were seeded in 96-well plates at a
density of 5000 cells/well. At time points 1, 3 and 5 days,
the CCK-8 assay was performed by adding 10 μL of the
CCK-8 solution (Dojindo Molecular Technologies, Inc.
Japan) to each well and incubating for 1.5 h according to
manufacturer’s protocol. The absorbance was measured
at λ = 450 nm on a plate reader. Results were demon-
strated as the absorbance of each experimental well
minus the optical density value of blank wells. All sam-
ples were repeated in triplicate with three independent
experiments.
Alkaline phosphatase activity
Alkaline Phosphatase activity was analyzed colorimetri-
cally using alkaline phosphatase assay kit (Nanjing Jian-
cheng Bioengineering Insitute, China) using a starting
seeding density of 50,000 cells per 24 well dish as previ-
ously described [30, 31]. At time point of 7 and 14 days,
cells were washed three times with PBS and solubilized
in 0.1 % Triton X-100 at 4 °C for 1 h. After sonication
and centrifugation, ALP activity in the supernatant was
determined colorimetrically using readings OD405/
OD562. Samples were run in triplicate with three inde-
pendent experiments performed and normalized to total
DNA content.
Fig. 1 Scanning electron microscopy image of BCP scaffolds at low and high magnification demonstrated many macro- and nano-topographies
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Real-time PCR
MC3T3-E1 cells were seeded at a starting seeding dens-
ity of 50,000 cells per 24 well dish and cultured for 7
and 14 days as previously described [31, 32]. The effects
of 1) control tissue culture plastic, 2) 10 mg of BCP
alone, 3) rhBMP2 at concentrations of 100 ng/ml and 4)
rhBMP2 at a concentration of 100 ng/ml + 10 mg BCP
were investigated on four osteogenic-related gene ex-
pression including runt-related transcription factor 2
(Runx 2), collagen I (COLI), alkaline phosphatase (ALP)
and osteocalcin (OCN). Total RNA was extracted from
MC3T3-E1 cells by Trizol reagent (TriPure Isolation Re-
agent, Roche Applied Science, Germany) according to
the manufacturer’s instructions. The concentration and
quality of the total RNA samples was carried out by
Nanodrop (Thermo Fisher Scientific Inc.). Complemen-
tary DNA was synthesized from 2 μg of total RNA using
RevertAidTm First Strand cDNA Synthesis Kit (Fermen-
tas) following the manufacturer’s protocol. RT-qPCR
was performed in 20 μL reactions containing 10 μl SYBR
Green Master Mix (Roche Applied Science, Germany),
0.6 μL (10 μM) of each forward and reverse primer
for each gene of interest, 2 μL of cDNA template and
6.8 μL water. Glyceraldehyde-3-phosphate-dehydro-
genase (GAPDH), a reference gene, was used as a
control. The reaction was carried out using an ABI
Prism 7000 Sequence Detection System (Applied Bio-
systems), and the PCR amplification run for 40 cycles.
To validate specific amplicon amplification without
genomic DNA contamination, melting curve analysis
was performed and the single apex appeared around
the annealing temperature. Relative expression levels
for each desired gene were normalized against the Ct
value of GAPDH and determined by using the delta
Ct method. All samples were determined in triplicate
for three independent studies.
Alizarin red quantification
Alizarin red staining was performed to determine the
presence of extracellular matrix mineralization after
14 days. MC3T3-E1 cells were seeded at a density of
50’000 cells per 24 well culture dish containing 1) con-
trol tissue culture plastic, 2) 10 mg of BCP alone, 3)
rhBMP2 at concentrations of 100 ng/ml and 4) rhBMP2
at a concentration of 100 ng/ml + 10 mg BCP. After
14 days, cells were fixed in 96 % ethanol for 15 min and
stained with 0.2 % alizarin red solution in water (pH 6.4)
at room temperature for 1 h and visualized under light
microscopy. Thereafter, alizarin red quantification was
dissolved using 200 μl of 1 % cetylpyridinium chloride
(dissolved with double distilled water) at room
temperature for 4 h. Then 100 μl solution was trans-
ferred to 96-well plate to text OD 560. Thereafter sam-
ples were normalized to control samples which included
first BCP bone grafts alone without cells (for BCP group
ad BCP + rhBMP2 group only), and thereafter to control
tissue culture plastic samples as previously described [5].
Statistical analysis
All data analysis was performed using SPSS 17.0 soft-
ware and statistically significant values were adopted as
p < 0.05. Mean and standard deviation (SD) were ana-
lyzed using one-way ANOVA with a post hoc t-test. Use
of ANOVA assumes that the data are normally distrib-
uted, and that the variances of the different groups do
not differ significantly.
Results
Migration assay
A transwell assay was used to investigate the effects of
rhBMP2 and BCP grafts on cell recruitment (Fig. 2a). It
was first found that BCP alone had no ability to recruit
MC3T3-E1 cells when compared to control samples
whereas 100 ng/ml of rhBMP2 was able to significantly
upregulate cell recruitment (p < 0.05). The combination
approach utilizing BCP with 100 ng/ml of rhBMP2 was
Fig. 2 a Cell recruitment assay demonstrated that 100 ng/ml of
rhBMP2 is significantly able to improve MC3T3-E1 cell recruitment
(Cell number per field of view). b Proliferation assay of MC3T3-E1
cells seeded at 1, 3 and 5 days post seeding demonstrated that no
further advantage of combining rhBMP2 with BCP or BCP alone
could be observed cell number of MC3T3-E1 cells demonstrated that
the combination of rhBMP2 + BCP significantly increased numbers at
3 and 5 days post seeding when compared to rhBMP2 alone or BCP
alone (*, p < 0.05, denotes significant difference between group and
control, ** p <0.05, denotes significantly higher than all other groups)
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unable to further increase cell recruitment when com-
pared to rhBMP2 alone (Fig. 2a).
Cell growth assay
The proliferation of MC3T3-E1 cells was then investi-
gated to determine the effects of each group on cell
number (Fig. 2b). It was found that at 1 day post seed-
ing, all cells adhered and were present in similar num-
bers. By 3 days however, cells that were seeded in the
presence of 100 ng/ml of rhBMP2 or BCP demonstrated
significantly higher cell numbers when compared to con-
trol samples (p < 0.05, Fig. 2b). Furthermore, the com-
bination of rhBMP2 with BCP displayed significantly
higher levels then all other groups (**p < 0.01). At 5 days
post seeding, a significant increase between BCP and
control samples could be observed. Additionally,
rhBMP2 further stimulated cell numbers when com-
pared to control, and the combination of BCP + rhBMP2
led to significantly higher cell number when compared
to all other treatment groups (p < 0.05, Fig. 2b).
Differentiation assays
In order to assess osteoblast differentiation, alkaline
phosphatase activity, alizarin red staining and mRNA
levels of osteoblast differentiation markers were investi-
gated (Figs. 3, 4 and 5). It was first observed that the use
of both BCP and rhBMP2 significantly increased ALP
activity over three fold when compared to control samples
at both 7 and 14 days post seeding (Fig. 3). Moreover,
rhBMP2 demonstrated significantly higher ALP expres-
sion when compared to BCP at both time points (Fig. 3).
The combination of BCP scaffolds with rhBMP2 led to
significantly higher ALP activity when compared to all
other treatment groups at both 7 and 14 days (Fig. 3).
Real time PCR was then investigated to analyze the
following four genes Runx2, COL-1, ALP and OCN
(Fig. 4). It was found that the addition of rhBMP2 or
BCP was able to significantly increase Runx2 expression
two fold at 7 and 14 days (Fig. 4a). Furthermore, group
containing rhBMP2 + BCP led to significantly higher
levels when compared to all other groups at 7 days
(Fig. 4a). Expression of COL-1 showed that cell seeded
with BCP demonstrated significantly higher levels when
compared to all other treatment modalities at both 7
and 14 days (Fig. 4b). ALP activity was significantly in-
creased approximately ten fold for BCP and rhBMP2 at
both time points with rhBMP2 + BCP demonstrating sig-
nificantly higher levels when compared to all other
groups at both 7 and 14 days (Fig. 4c). No significant
changes for OCN expression was observed at 7 days
(Fig. 4d), however, at 14 days, over a 150 fold increase
could be observed in BCP and rhBMP2 groups when
compared to controls (Fig. 4d). Furthermore, rhBMP2 +
BCP group demonstrated significantly higher OCN
expression when compared to all other modalities
(Fig. 4d).
Alizarin red staining was then utilized to visualize the
mineralization potential of each sample (Fig. 5). In the
absence of osteoblast differentiation media, it was ob-
served that control samples had no ability to produce
mineralization following 14 days culture (Fig. 5). In the
group receiving rhBMP2, evidence of mineralization was
apparent via alizarin red staining (Fig. 5, red dots). The
samples with BCP alone also demonstrated signs of
mineralization potential primarily found in cells around
the bone grafting particles. The samples containing both
Fig. 3 ALP activity was significantly increased at 7 and 14 days post
seeding for samples seeded with 1) control tissue culture plastic, 2)
BCP alone 3) 100 ng rhBMP2, and 4) 100 ng rhBMP2 + BCP (*p < 0.05,
denotes significant differences between groups, ** p <0.05, denotes
significantly higher than all other groups)
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BCP and rhBMP2 demonstrated signs of elevated stain-
ing with apparent staining around the bone grafting par-
ticles (Fig. 5). Quantification of alizarin red data
demonstrated that the combination of rhBMP2 with
BCP significantly increased mineralization when com-
pared to all other groups (Fig. 5).
Discussion
The aim of the present study was to investigate whether
the combination of rhBMP2 could further enhance
osteoblast activity by combining its osteoinductive prop-
erties with novel BCP bone grafts. These new grafts have
been shown to be osteoinductive by demonstrating signs
of ectopic bone formation in various animal models
[16, 17]. Recent investigations on their mode of ac-
tion have suggested that these grafts promote rapid
transformation from mesenchymal progenitor cell to
osteoblasts, a phenomenon that appears to be guided
by surface topography and dissolution of the material
composition. However, a complete understanding is
still lacking [18, 33–38]. While a wide variety of work
is still necessary to better understand the main factors
driving their ability to enhance ectopic bone formation,
recent animal models confirm that these synthetically fab-
ricated grafts are equally or more potent at forming new
bone when compared to other synthetic bone grafting
materials commercially available [39, 40]. Thus, it be-
comes of interest to design new strategies to implement
these bone grafts with osteoinductive growth factors to
further enhance new bone formation.
One of the key principles in designing new biomate-
rials involves key understandings of the biomaterial
characteristics necessary to further enhance new bone
formation. As such, guidelines have previously been
established in a recent review article published by our
group [7]. In order to facilitate osteoinduction, three key
principals are necessary for improved osteoinductive po-
tential of biomaterials [7]. Firstly, an ability to recruit
Fig. 4 mRNA levels of a RUNX2, b COL-1, c ALP and d OCN for MC3T3-E1 cells seeded on 1) control tissue culture plastic, 2) BCP alone 3) 100 ng
rhBMP2, and 4) 100 ng rhBMP2 + BCP at 7 and 14 days post seeding (*p < 0.05, denotes significance between groups, # p < 0.05, denotes significantly
lower than all other treatment groups, ** p < 0.05, denotes significantly higher than all other treatment groups)
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mesenchymal progenitor cells to defect sites and bioma-
terial surfaces is crucial to the future success of their re-
generative potential [7]. Secondly, the ability for the
biomaterial to guide rapid differentiation of cells down
the osteoblast lineage is necessary [7]. Lastly, all osteoin-
ductive biomaterials should demonstrate the potential to
form ectopic bone formation per guidelines established
by Urist et al. in the mid 1960s [14, 15]. Thus, the combin-
ation of rhBMP2 with BCP scaffolds provides evidence of
these concepts by providing additional biological rational.
While rhBMP2 is able to improve principle 1 by recruiting
progenitor cells to defect sites, once the cells have reached
the material surface BCP scaffolds are then able to facili-
tate their differentiation towards the osteoblast lineage
(principle 2). Furthermore, both of these materials alone
are able to induce ectopic bone formation in extra-skeletal
sites (principal 3).
The results from the present study demonstrate that
rhBMP2 is able to recruit progenitor cells as found in
our transwell assay (Fig. 2). The addition of BCP did not
improve cell recruitment nor did BCP alone. This is
likely due to the fact that BCP scaffolds contain no
growth factors or chemokines able to recruit progenitor
cells. When cell proliferation was analyzed, it was found
that the combination of bone rhBMP + BCP significantly
enhanced cell numbers at both 3 and 5 days post seed-
ing when compared to rhBMP2 alone or to BCP alone
(Fig. 2b). Thus, the use of bioactive biomaterials further
supported the proliferation of cells and that their com-
bination did provide additional benefit. However and
more notably, most of the drastic differences were ob-
served when cell differentiation was analyzed. It was
found in the present study that ALP activity was induced
over three fold with either BCP alone or rhBMP2 alone
at 7 and 14 days post seeding and this could be further
enhanced when their combination was utilized (Fig. 3).
Not surprisingly, all genes associated with osteoblast dif-
ferentiation were further significantly increased when
mRNA levels were assessed by real-time PCR for groups
including either rhBMP2, BCP or a combination of
Fig. 5 a Qualitative analysis of alizarin red staining to demonstrate areas of mineralization in MC3T3-E1 cells seeded on 1) control tissue culture
plastic, 2) BCP alone, 3) 100 ng rhBMP2, and 4) 100 ng rhBMP2 + BCP at 14 days post seeding. b Percentage of mineralization area from alizarin
red staining (* p < 0.05 denotes significant difference between group and control, ** p <0.05, denotes significantly higher than all other treatment)
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rhBMP2 + BCP. It must also be pointed out that under
the present in vitro setting, the data indicate that the use
of rhBMP2 alone seemed to favour osteoblast differenti-
ation more so then when BCP alone was utilized. The
results clearly point to the osteoinductive ability of
rhBMP2 on osteoblast activity. From a clinical perspec-
tive, it must be noted that the use of a bone grafting ma-
terial provides significant other advantages apart from
cell activity which include maintaining provisional space
for defect healing as well as improving blood clot forma-
tion; two important factors in defect wound healing [41].
Interestingly, while genes encoding Runx2 and colla-
gen1 at 7 and 14 days post seeding demonstrated at
most a 2–3 fold upregulation across all tested experi-
mental groups, ALP activity demonstrated a marked
ten-fold increase at 7 days post seeding, and a 20 fold in-
crease at 14 days post-seeding (Fig. 4). Furthermore,
while OCN was elevated approximately 1.5 fold at 7 days
post seeding, the gene expression of OCN raised over
200 fold by 14 days post-seeding for groups containing
rhBMP2 (Fig. 4d). OCN is largely considered a late dif-
ferentiation marker of osteoblasts. This finding is likely
indicated that MC3T3-E1 pre-osteoblasts had not
undergone full differentiation by 7 days, and that by
14 days had reached full maturity. Thus when the fully
matured cells where compared to control undifferenti-
ated cells which were cultured on cell culture plastic
without rhBMP2 or BCP, it becomes apparent that these
cells are not expressing OCN in high levels.
Interesting results were observed for alizarin red stain-
ing (Fig. 5). No staining was observed in control samples
further confirming that these cells had not undergone
cell differentiation and thus had no apparent ability to
produce mineralized tissue in vitro. Cells that were cul-
tured with rhBMP2 on the other hand produced droplets
of alizarin red staining which were not found in levels
consistent throughout the entire culture surface but in-
stead were found in cluster regions which expressed
highly mineralized areas (Fig. 5, rhBMP2 alone sample). It
was further interesting to observe that in samples cultured
with BCP bone grafting materials, much of the staining
was observed around the bone grafting particles (Fig. 5)
Thus, it becomes evident that either the dissolution of the
bone grafting material is influencing the surrounding cell’s
ability to differentiate and produce mineralized tissue, or
that somehow cells adjacent to the material surface are
able to communicate to adjacent cells via cell-cell commu-
nication molecules such as connexins and gap junctions
able to influence osteoblast differentiation. A further
understanding of these observed results could provide
additional cues as to how these scaffolds are able to
further increase osteoblast differentiation.
One area of research that remains to be addressed is
the mechanism by which these novel osteoinductive
bone grafts are able to stimulate ectopic bone formation.
Recent studies have revealed that the immune system
and the field of osteoimmunology is likely to provide the
key features to certain synthetic bone grafts being
osteoinductive [18, 20, 27]. An animal macrophage
knock-out system revealed that the elimination of
macrophage completely abolished the osteoinductive po-
tential of these BCP grafts [18, 20, 27]. This special sub-
set of macrophages which has been refered to in the
literature as ‘OsteoMacs’ (short for osteal macrophages)
is currently a key area of research focusing on their pos-
sible role in guiding new bone regeneration around cer-
tain classes of bone biomaterials [42]. While data exist
supporting their involvement to date, further investiga-
tion into new strategies to fully reveal their implication
in bone formation will likely provide key valuable in-
sights into future development of osteoinductive bone
biomaterials since monocytes/macrophages are one of
the first cell-type in contact with biomaterials and likely
govern their future integration into host tissues.
Conclusions
The results from the present study demonstrate that
rhBMP2 was able to increase cell recruitment whereas
its combination with BCP did not provide any additional
benefit. Cell numbers were significantly higher at 3 and
5 days post seeding for the combination of rhBMP2 +
BCP when compared to rhBMP2 alone and BCP alone.
Interestingly, it was observed that these new BCP bone
grafts were equally as osteopromotive when compared
to rhBMP2 on in vitro osteoblast differentiation. Fur-
thermore, the combination of both biomaterials had a
further significant increase on cell differentiation as
assessed by real-time PCR, ALP activity and alizarin red
staining. The results from the present study suggest that
the combination of both materials may improve the speed
and quality of new bone formation in vivo, however future
animal testing is required to validate this hypothesis.
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